Tag: Inmagene Biopharmaceutical
China’s Inmagene Biopharmaceuticals Closes $21m Series B Funding
Inmagene Biopharmaceuticals, one of China's immunology drug development companies, has closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by...